These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 830403)
1. The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines. Goss P; Parsons PG Cancer Res; 1977 Jan; 37(1):152-6. PubMed ID: 830403 [TBL] [Abstract][Full Text] [Related]
2. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines. Parsons PG Cancer Res; 1984 Jul; 44(7):2773-8. PubMed ID: 6722805 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of melphalan resistance developed in vitro in human melanoma cells. Parsons PG; Carter FB; Morrison L; Regius Mary Sister Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526 [TBL] [Abstract][Full Text] [Related]
4. Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation. Raaphorst GP; Bussey A; Heller DP; Ng CE Radiat Res; 1994 Mar; 137(3):338-45. PubMed ID: 8146277 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid effect on melphalan cytotoxicity, cell-cycle position, cell size, and [3H]uridine incorporation in one of three human melanoma cell lines. Benckhuijsen C; Osman AM; Hillebrand MJ; Smets LA Cancer Res; 1987 Sep; 47(18):4814-20. PubMed ID: 3621177 [TBL] [Abstract][Full Text] [Related]
6. Effect of sequential application of hyperthermia and chemotherapy on the survival of a thermoresistant human melanoma cell line. Greco C; Cavaliere R; Giovanella B; Natali PG; Zupi G Cancer Biochem Biophys; 1987 Sep; 9(3):223-32. PubMed ID: 3435895 [TBL] [Abstract][Full Text] [Related]
7. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells. Parsons PG; Morrison LE Cancer Res; 1982 Sep; 42(9):3783-8. PubMed ID: 6809313 [TBL] [Abstract][Full Text] [Related]
8. Results of hyperthermic perfusion for melanoma of the extremities. Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425 [TBL] [Abstract][Full Text] [Related]
9. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor. Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851 [TBL] [Abstract][Full Text] [Related]
10. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Hansson J; Lewensohn R; Ringborg U; Nilsson B Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of human cells to mild hyperthermia. Armour EP; McEachern D; Wang Z; Corry PM; Martinez A Cancer Res; 1993 Jun; 53(12):2740-4. PubMed ID: 8504414 [TBL] [Abstract][Full Text] [Related]
12. Zinc-induced reduction in melphalan cytotoxicity: heterogeneity of response of cloned human tumor cells. Tobey RA; Tesmer JG; Shackelford ME J Cell Physiol; 1987 May; 131(2):235-9. PubMed ID: 3584249 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma. Zaffaroni N; Villa R; Daidone MG; Vaglini M; Santinami M; Silvestrini R Int J Cell Cloning; 1989 Nov; 7(6):385-94. PubMed ID: 2809274 [TBL] [Abstract][Full Text] [Related]
14. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation. Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916 [TBL] [Abstract][Full Text] [Related]
15. Acute extracellular acidification reduces intracellular pH, 42 degrees C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7. Coss RA; Storck CW; Wachsberger PR; Reilly J; Leeper DB; Berd D; Wahl ML Int J Hyperthermia; 2004 Feb; 20(1):93-106. PubMed ID: 14612316 [TBL] [Abstract][Full Text] [Related]
16. Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro. Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ Anticancer Res; 1990; 10(3):789-93. PubMed ID: 2369092 [TBL] [Abstract][Full Text] [Related]
17. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968 [TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218 [TBL] [Abstract][Full Text] [Related]
19. Arrhenius relationships from the molecule and cell to the clinic. Dewey WC Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695 [TBL] [Abstract][Full Text] [Related]
20. Melphalan-induced chromosome damage in sensitive and resistant human melanoma cell lines. Parsons PG; Morrison L Int J Cancer; 1978 Apr; 21(4):438-43. PubMed ID: 669848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]